openPR Logo
Press release

At 5.6% Growth, North America In-vitro Diagnostics Market to reach $39bn by 2024: Abbott, Johnson & Johnson, Siemens, Sorin, Thermo Fisher

02-21-2019 05:44 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Medical Devices and Pharma

/ PR Agency: In-vitro Diagnostic Market
In-vitro Diagnostic Market

In-vitro Diagnostic Market

Key industry competitors operating in North America in-vitro diagnostics market are Abbott, Becton Dickinson, BioRad, BioMerieux, Cephied, Danaher, Grifols, Johnson & Johnson, Luminex, Roche Diagnostics, Siemens, Sorin, Thermo Fisher and Qiagen. Strategic initiatives adopted by prominent industry players will help them to sustain the market competition. For instance, in September 2016, Becton Dickinson launched next-generation wireless diagnostic system for detection of influenza A and B, thereby expanding its product portfolio.

According to the Graphical Research new growth forecast report titled “North America In-vitro Diagnostics Market estimated to exceed USD 39 billion by 2024.

Request for a sample of this research report - https://www.graphicalresearch.com/request/1033/sample

Integration of advanced technology within the diagnostic devices will improve accuracy and efficiency of these devices that should have a positive impact on in-vitro diagnostics industry growth. Technologically advanced countries such as the U.S. and Canada focus their efforts on R&D to manufacture automated laboratory diagnostic machines and equipment for accurate detection of diseases. For instance, companies such as Qaigen, provides point of care molecular diagnostic devices possessing highest accuracy and the results are displayed on the computers for complete analysis escalating its preference in the coming years over other conventional options available.

In-vitro diagnostics market should grow significantly as a result of increasing prevalence of chronic diseases such as diabetes and cancer. As reported by National Cancer Institute, in 2018, there will be 1,735,350 cases of cancer that will escalate the business growth significantly in the near future. However, high costs associated with the diagnostic devices may affect industry growth.

Reagents & kits segment will grow at 6.6% during the forecast timeframe owing to escalating demand for such product types used in diagnosis of viral, fungal and bacterial diseases. Moreover, manufacturers have improvised on product offerings by providing molecular reagents and kits of better quality. For instance, development of superior quality SDS PAGE electrophoresis reagents for a better analysis and detection of diseases at gene level will upsurge the segmental growth.

Data management software segment accounted for 20.7% revenue share in 2017 and the segmental growth can be accounted to high efficiency of software available that are reliable and proficient in managing the patient data. Above-mentioned will increase its preference over other software available for keeping track of diseases thereby, should favor segmental growth.

Molecular diagnostics technology segment will grow at 8.3% CAGR over the forecast timeframe. The high segmental growth can be accounted to increasing prevalence of genetic diseases demanding critical monitoring and novel target therapy at gene level. Moreover, growing use of molecular diagnostic devices in process of drug discovery will augment business growth in the upcoming years.

Browse key industry insights from this 2018 report North America In-vitro Diagnostics Market in detail along with the table of contents at:
https://www.graphicalresearch.com/industry-insights/1033/north-america-in-vitro-diagnostics-market

Diabetes segment was valued at USD 3.9 billion in 2017 and is expected to have high growth rate as a result of growing prevalence of diabetes in developed countries due to increasing incidences of obesity amongst the individuals. Availability of superior quality glucose detecting diagnostic devices enabling quick and reliable results will escalate business growth.

Point-of-care segment had enormous market size of USD 6.2 billion in 2017 and the high growth of the segment can be accounted to the growing use of point-of care molecular diagnostic devices for detecting blood glucose levels even at home. Hospitals have also adopted the point-of-care diagnostic devices that will impact the segmental growth positively.

U.S. in-vitro diagnostics market should witness high growth and held a momentous share of USD 23.9 billion in as a result of high prevalence of viral infections in the U.S. population including Zika virus leading to increasing demand for in vitro diagnostics. According to CDC 2017 reports statistics estimated that 5,710 people were suffering from Zika virus infection. These infected people need an advanced diagnostic testing to diagnose the disease, thereby augmenting the in-vitro diagnostics market growth.

Make an inquiry for purchasing this report @ https://www.graphicalresearch.com/request/1033/inquiry-before-buying

Segments We Cover:

In-vitro Diagnostics Market Statistics, By Product Type
Reagents & kits, Instruments

In-vitro Diagnostics Market Trends, By Service Type
Data Management Software, Services

In-vitro Diagnostics Market Growth, By Technology
Clinical Chemistry, Immunoassay/Immunochemistry,Molecular Diagnostics, Hematology, Microbiology, Coagulation and Hemostasis, Urinalysis, Other

In-vitro Diagnostics Market, By Application
Oncology, Infectious Diseases, Diabetes, Cardiology, Nephrology, Autoimmune Diseases, Drug Testing/Pharmacogenomics, Other

In-vitro Diagnostics Market, By End-user
Hospitals, Point-Of-Care Testing, Laboratories, Academic Institutes, Other

The above information is provided for the following countries:
U.S, Canada

About Graphical Research:

Graphical Research is a business research firm that provides industry insights, market forecast and strategic inputs through granular research reports and advisory services. We publish targeted research reports with an aim to address varied customer needs, from market penetration and entry strategies to portfolio management and strategic outlook. We understand that business requirements are unique: our syndicate reports are designed to ensure relevance for industry participants across the value chain. We also provide custom reports that are tailored to the exact needs of the customer, with dedicated analyst support across the purchase lifecycle.

Contact Us:

Parikhit B.
Corporate sales,
Graphical Research
Email: sales@graphicalresearh.com
Web: https://www.graphicalresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release At 5.6% Growth, North America In-vitro Diagnostics Market to reach $39bn by 2024: Abbott, Johnson & Johnson, Siemens, Sorin, Thermo Fisher here

News-ID: 1605046 • Views:

More Releases from Medical Devices and Pharma

Asia Pacific Dental Implants Market 2019-2024 | Industry Analysis by Key Players Danaher Corporation, Straumann, Dentsply Sirona, Zimmer Biomet, Henry Schein
Asia Pacific Dental Implants Market 2019-2024 | Industry Analysis by Key Players …
Graphical Research has launched a report on Asia Pacific Dental Implants Market that elucidates an in-depth synopsis of this business vertical over the forecast period. The report is inclusive of the prominent industry drivers and provides an accurate analysis of the key growth trends and market outlook in the years to come in addition to the competitive hierarchy of this sphere. Rising prevalence of edentulism in developing countries such as India
North America In-vitro Diagnostic Market Growth Analysis and Forecast 2024 | Key Players Abbott, Qiagen, Becton Dickinson, BioRad, Cephied, Johnson & Johnson, Roche
North America In-vitro Diagnostic Market Growth Analysis and Forecast 2024 | Key …
Graphical Research provides a detailed overview of North America In-vitro Diagnostic Market with respect to the pivotal drivers influencing the revenue graph of this business sphere. The current trends of In-vitro Diagnostic Market in conjunction with the geographical landscape, demand spectrum, remuneration scale, and growth graph of this vertical have also been included in this report. Integration of advanced technology within the diagnostic devices will improve accuracy and efficiency of these
APAC Biomedical Refrigerators and Freezers Market Outlook 2019 with Key Participants Arctiko, Azbil Corporation, B Medical Systems, Thermo Fisher Scientific, Binder, Liebherr International, Follett, Haier Biomedical
APAC Biomedical Refrigerators and Freezers Market Outlook 2019 with Key Particip …
Graphical Research has recently added a report on APAC Biomedical Refrigerators and Freezers Market which provides a succinct analysis of the market size, revenue forecast, and the regional landscape of this industry. The report also highlights the major challenges and current growth strategies adopted by the prominent companies that are a part of the dynamic competitive spectrum of this business sphere. Rising elderly population coupled with growing disease burden in
North America Cell Line Development Market to witness growth of 12.5% by 2024
North America Cell Line Development Market to witness growth of 12.5% by 2024
A comprehensive research study on North America Cell Line Development Market introduced by Graphical Research provides insights into the market size and growth trends of this industry over the forecast timeline. The study evaluates key aspects of the market in terms of the demand landscape, driving factors and growth strategies adopted by market players. Growing demand for monoclonal antibodies, technological advancements in cell line development equipment and growing number of

All 5 Releases


More Releases for Diagnostic

Tenet Diagnostic: Reshaping the Diagnostic Industry in India
Tenet Diagnostic was incorporated in 2018 with an aim to establish high-quality diagnostics laboratories across India. The company caters to both B2B and B2C. They have seven different verticals namely: End Customer (B2C), Lab to Lab Test Outsourcing, Corporates and Institutions, large management (Hospitals, Medical Colleges, and other healthcare institutions), Clinical Trials, Home Sample Collection, and Government PPP Projects. Tenet Diagnostics got its NABL certification in the fastest time and is
Global Tissue Diagnostic Market 2020 Business Strategies – Roche Diagnostic, A …
The Zion Market Research added a new report “Tissue Diagnostic Market by Product Type (Consumables and Instruments), by Technology (Immunohistochemistry (IHC), in Situ Hybridization (ISH), Digital Pathology and Workflow Management, and Special Staining), by Diseases (Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non-Small Cell Lung Cancer (NSCLC), and Others), and by End-users (Hospitals, Research Laboratories, Ambulatory Surgical Centers, Diagnostic Centers, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017
Diagnostic Imaging Services Market 2019 Analyzed by Top Key Players PH3 Healthca …
Big Market Research has added a report, titled, "Diagnostic Imaging Services" The report not only provides a comprehensive analysis of market overview and dynamics for the historical period, 2019-2026, but also offers global and regional forecasts on market value, volume production, and consumption during the future period, 2019-2026. The report also analyzes the key market players, especially the distributors, along with the industrial chain structure. The evolution of market trends
POC Cardiovascular Diagnostic Market Report 2018: Segmentation by Product (Diagn …
Global POC Cardiovascular Diagnostic market research report provides company profile for F. Hoffmann-La Roche, Siemens, Abbott, Biomerieux, Danaher and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc. The report also provides detailed segmentation on
Cervical Dysplasia Diagnostic Market - by Diagnostic, and End Users
Cervical infection is major risk factor for progression of HPV. Currently, conventional Pap smear test or HPV test are the only test available for screening cervical infection, which in turn propels the demand for development of DNA-based molecular testing to detect human papillomavirus for diagnosis of cervical cancer. For instance, in 2016, Becton, Dickinson and Company received pre-diagnostic market approval from FDA for its Onclarity HPV assay, type of HPV
Diagnostic Imaging Services Market Trending Technologies and Company Overview 20 …
Diagnostic Imaging Services market research report provides the newest industry data and industry future trends, allowing you to identify the products and end users driving Revenue growth and profitability. The industry report lists the leading competitors and provides the insights strategic industry Analysis of the key factors influencing the market. The report includes the forecasts, Analysis and discussion of important industry trends, market size, market share estimates and profiles of the